Similar articles

• [Importance of factor II determination during treatments with vitamin K inhibitors].

  Plouvier SR, Arnold M. Plouvier SR, et al. Agressologie. 1971;12(1):41-8. Agressologie. 1971. PMID: 5314460 French. No abstract available.
• [Intramural hematoma of the digestive tract from vitamin K antagonists].

  Costecalde M, Pradère B, Parent Y, Barret A, Gouzi JL, Gédéon A. Costecalde M, et al. Ann Chir. 1984 Feb;38(1):31-6. Ann Chir. 1984. PMID: 6608911 French. No abstract available.
• Reversal of vitamin K antagonist-associated coagulopathy: a survey of current practice.

  Neal M, Crowther M, Douketis J, Verhovsek M, Stidley C, Garcia D. Neal M, et al. Thromb Res. 2008;122(6):864-6. doi: 10.1016/j.thromres.2008.06.003. Epub 2008 Aug 3. Thromb Res. 2008. PMID: 18678398 No abstract available.
• [Biological monitoring and prevention of complications from antithrombotic agents].

  Samama MM, Kher A. Samama MM, et al. Arch Mal Coeur Vaiss. 1996 Nov;89(11 Suppl):1569-77. Arch Mal Coeur Vaiss. 1996. PMID: 9092420 Review. French.
• [When is antivitamin K therapy indicated in the stable coronary patient?].

  Ferrari E, Serre S, Lesto I, Berkane N, Baudouy M. Ferrari E, et al. Arch Mal Coeur Vaiss. 2001 Nov;94(11 Suppl):1274-7. Arch Mal Coeur Vaiss. 2001. PMID: 11794969 Review. French.